Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwri - GuruFocus
Yesterday • Google News
Mirum Pharmaceuticals Inc (MIRM)
US$ 48.880.91%
Price Chart
Key Statistics
Market Cap
$ 2.22B
P/E Ratio
0.00
Revenue (TTM)
$ 379.25M
Volume
438.69K
52W High
$ 54.23
52W Low
$ 23.83
Dividend Yield
0.00%
Beta
0.96
Technicals
50-Day MA
43.2034
200-Day MA
43.1825
52 Week High
54.234
52 Week Low
23.83
About MIRM
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
Employees
334
Headquarters
Foster City, CA
CEO
Mr. Christopher Peetz
Latest News
Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - Stock Titan
Yesterday • Google News
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg